Genomic-sequencing company ArcherDX raises $35M
BOULDER — ArcherDX Inc., a Boulder-based company that develops genomic sequencing assays and analysis software, has closed a Series A funding round, raising $35 million.
Boulder Ventures Ltd. and PBM Capital Group LLC led the funding round, with Longwood Fund and Peierls Foundation also participating.
Kyle Lefkoff of Boulder Ventures has joined the ArcherDX board of directors.
A Form D filed with the U.S. Securities and Exchange Commission, March 20, reported $37.64 million in equity financing raised by the company.
The capital infusion comes after a year of record growth for ArcherDX and penetration…
THIS ARTICLE IS FOR SUBSCRIBERS ONLY
Continue reading for less than $3 per week!
Get a month of award-winning local business news, trends and insights
Access award-winning content today!